Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

April 30, 2020

Conditions
Asthma
Interventions
DRUG

Beclomethasone 800 µg per day

Intervention: Drug: Beclomethasone 800 µg HFA per day

DRUG

Placebo

Intervention: Drug: placebo

DRUG

Beclomethasone 400 µg per day

Intervention: Drug: Beclomethasone 400 µg HFA per day

DRUG

Beclomethasone 640 µg per day

Intervention: Drug: Beclomethasone 640 µg per day

All Listed Sponsors
lead

Adamis Pharmaceuticals Corporation

INDUSTRY